Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	26.76	61.58	9.24	20.99	55.89	63.83
Short-Term Investments	147.38	165.34	-	22.76	-	-
Cash & Short-Term Investments	174.14	226.92	9.24	43.76	55.89	63.83
Cash Growth	-34.99%	2356.33%	-78.89%	-21.71%	-12.44%	2568.39%
Accounts Receivable	0.18	0.12	1.17	1.36	1.61	2.01
Other Receivables	-	1.37	0.01	0	0.02	0.03
Receivables	0.18	1.48	1.18	7.47	1.63	2.05
Inventory	-	-	-	-	1.4	0.98
Prepaid Expenses	4.18	2.68	1.08	0.44	0.39	0.42
Other Current Assets	-	0.08	5.35	1.54	0.03	0.03
Total Current Assets	178.5	231.16	16.84	53.22	59.33	67.3
Property, Plant & Equipment	65.89	59.54	6.32	0.37	2.49	2.73
Long-Term Investments	-	0.13	0.13	0.15	-	-
Goodwill	-	-	24.06	-	-	-
Other Intangible Assets	50	50.01	50.35	0.03	0.11	0.13
Other Long-Term Assets	0.44	0.27	0.18	4.33	2.52	0.26
Total Assets	294.83	341.1	97.89	58.09	64.44	70.42
Accounts Payable	12.95	9.84	6.41	1.54	0.97	0.73
Accrued Expenses	6.71	5.48	3.59	1.3	1.03	0.82
Current Portion of Long-Term Debt	0.06	0.05	0.05	-	-	-
Current Portion of Leases	0.7	0.96	0.05	-	0.27	0.25
Current Unearned Revenue	-	1.4	-	-	-	-
Other Current Liabilities	0.2	0.5	5.57	0.28	-	-
Total Current Liabilities	20.62	18.23	15.66	3.12	2.27	1.8
Long-Term Debt	1.58	1.63	1.68	-	-	-
Long-Term Leases	0.97	1.43	0.78	-	0.26	0.52
Long-Term Unearned Revenue	26.6	26.6	-	-	-	-
Long-Term Deferred Tax Liabilities	2.5	2.5	4.59	-	-	-
Other Long-Term Liabilities	0.34	0.06	-	0.33	0.64	0.69
Total Liabilities	52.61	50.43	22.71	3.45	3.16	3.01
Common Stock	0.07	0.07	0.03	0.14	0.14	0.14
Additional Paid-In Capital	539.38	522.37	227.59	160.43	159.73	158.59
Retained Earnings	-297.35	-231.72	-152.44	-105.93	-98.6	-91.33
Comprehensive Income & Other	0.11	-0.05	-	-	-	-
Total Common Equity	242.22	290.67	75.18	54.64	61.28	67.41
Shareholders' Equity	242.22	290.67	75.18	54.64	61.28	67.41
Total Liabilities & Equity	294.83	341.1	97.89	58.09	64.44	70.42
Total Debt	3.31	4.06	2.55	-	0.52	0.78
Net Cash (Debt)	170.82	222.85	6.69	43.76	55.37	63.05
Net Cash Growth	-35.19%	3232.64%	-84.72%	-20.97%	-12.19%	4445.93%
Net Cash Per Share	2.34	3.46	0.25	3.08	3.90	6.07
Filing Date Shares Outstanding	74.34	74.05	58.69	28	14.21	14.19
Total Common Shares Outstanding	74.34	70.67	28.18	14.21	14.2	14.19
Working Capital	157.88	212.93	1.17	50.1	57.06	65.5
Book Value Per Share	3.26	4.11	2.67	3.84	4.31	4.75
Tangible Book Value	192.22	240.66	0.76	54.62	61.17	67.28
Tangible Book Value Per Share	2.59	3.41	0.03	3.84	4.31	4.74
Land	0.92	0.92	1.28	0.37	0.37	0.37
Buildings	1.77	1.77	1.77	-	-	-
Machinery	13.82	11.42	2.68	0.02	4.44	4.2
Leasehold Improvements	3.86	3.57	0.18	-	4.14	4.14

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q